Literature DB >> 16286575

Body mass index and angiotensin-dependent control of the renal circulation in healthy humans.

Sofia B Ahmed1, Naomi D L Fisher, Radomir Stevanovic, Norman K Hollenberg.   

Abstract

Obesity is increasingly recognized as a risk factor for renal disease, but the mechanism is unclear. Renal plasma flow response to captopril, as an index of renin-angiotensin system activity, was measured by para-aminohippurate clearance technique in 100 healthy, normotensive subjects in balance on a high-salt diet. Of the 100 subjects, body mass index exceeded 25 in 56 and exceeded 30 in 22. The average vasodilator response to captopril was 27+/-7 mL/min per 1.73 m2 (P<0.0001). After adjustment for other predictors of the renal plasma flow response to captopril using a multivariate linear regression model, there was a highly significant relationship between age- and plasma renin activity-adjusted body mass index and the renal plasma flow response to captopril; however, a quadratic model provided a substantially better fit (r=0.55; P<0.0001; P=0.03 versus linear correlation). The strong association between increasing body mass index and angiotensin-dependent control of the renal circulation suggests that this may be a mechanism by which obesity contributes to renal disease. Weight loss should be considered in the overweight or obese patient for renal protection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16286575     DOI: 10.1161/01.HYP.0000190819.07663.da

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  19 in total

1.  Improvement of Kidney Function Following Bariatric Surgery: Hope or Illusion?

Authors:  G Favre; A S Schneck; R Anty; V L M Esnault; A Iannelli
Journal:  Obes Surg       Date:  2015-10       Impact factor: 4.129

Review 2.  Hypertension in Obesity and the Impact of Weight Loss.

Authors:  Jordana B Cohen
Journal:  Curr Cardiol Rep       Date:  2017-08-24       Impact factor: 2.931

3.  Vitamin D and the vascular sensitivity to angiotensin II in obese Caucasians with hypertension.

Authors:  A Vaidya; J P Forman; J S Williams
Journal:  J Hum Hypertens       Date:  2010-12-02       Impact factor: 3.012

Review 4.  The kidney in obesity.

Authors:  Josep Redon; Empar Lurbe
Journal:  Curr Hypertens Rep       Date:  2015-06       Impact factor: 5.369

Review 5.  Cardiovascular consequences of metabolic syndrome.

Authors:  Johnathan D Tune; Adam G Goodwill; Daniel J Sassoon; Kieren J Mather
Journal:  Transl Res       Date:  2017-01-09       Impact factor: 7.012

Review 6.  Obesity and diabetic kidney disease.

Authors:  Christine Maric-Bilkan
Journal:  Med Clin North Am       Date:  2012-11-27       Impact factor: 5.456

Review 7.  Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis.

Authors:  Vivette D D'Agati; Avry Chagnac; Aiko P J de Vries; Moshe Levi; Esteban Porrini; Michal Herman-Edelstein; Manuel Praga
Journal:  Nat Rev Nephrol       Date:  2016-06-06       Impact factor: 28.314

8.  Obesity, Renin-Angiotensin System Blockade and Risk of Adverse Renal Outcomes: A Population-Based Cohort Study.

Authors:  Jordana B Cohen; Alisa J Stephens-Shields; Michelle R Denburg; Amanda H Anderson; Raymond R Townsend; Peter P Reese
Journal:  Am J Nephrol       Date:  2016-05-28       Impact factor: 3.754

Review 9.  The relationship between obesity and hypertension: an updated comprehensive overview on vicious twins.

Authors:  Massimo Leggio; Mario Lombardi; Elisa Caldarone; Paolo Severi; Stefania D'Emidio; Massimo Armeni; Veronica Bravi; Maria Grazia Bendini; Andrea Mazza
Journal:  Hypertens Res       Date:  2017-10-05       Impact factor: 3.872

Review 10.  [Hypertension and nutrition. Position paper of the Austrian Nutrition Society].

Authors:  T E Dorner; D Genser; G Krejs; J Slany; B Watschinger; C Ekmekcioglu; A Rieder
Journal:  Herz       Date:  2012-05-17       Impact factor: 1.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.